FDA hears from APC leaders
Earlier this week, APC’s Executive Committee and Federal Legislative Committee leaders met virtually with FDA’s Office of Compounding Quality + Compliance team to discuss a range of issues impacting pharmacy compounding.
Earlier this week, APC’s Executive Committee and Federal Legislative Committee leaders met virtually with FDA’s Office of Compounding Quality + Compliance team to discuss a range of issues impacting pharmacy compounding.
APC and the Pharmacy Compounding Foundation offer a series of briefing papers to help you educate prescribers about a range of pharmacy compounding topics.
Tennessee Governor Bill Lee has approved Senate Bill 753, which expands the state’s Board of Pharmacy from seven members to nine members and creating designated seats for a pharmacy technician and a consumer member.
We’re asking our members and supporters to send a message to your member of Congress, urging your elected officials to support legislative language enabling pharmacy compounders to help fill urgent gaps in the drug supply chain.
At its meeting this week in Alexandria, the APC Board of Directors unanimously elected Michelle Moser, Revelation Pharma/Makers Compounding Pharmacy, Mount Vernon, WA as Board Vice President for 2024.
PCCA hosted its ACT Conference in Washington, DC, this week, with more than 80 compounders attending and more than 130 Hill visits conducted. Here’s a photo composite recapping just a few of those.
Earlier this week, APC released an extensive statement on compounding copies of FDA approved drugs when those drugs are in shortage. The statement focuses in particular on semaglutide.
In the spirit of embracing the joy we feel as pharmacy compounders, the APC logo was recently refreshed to include our new “Compounding the Joy” tagline.
Medisca is supporting APC's “Compounding the Joy of Living” campaign by matching all individual contributions, dollar for dollar, up to $100,000.
The latest in APC’s suite of briefing documents for prescribers is available and it summarizes regulation governing the use of compounded medications for racehorses.